Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.

Sumarsono, Andrew; Sumarsono, Nathan; Das, Sandeep R; Vaduganathan, Muthiah; Agrawal, Deepak; Pandey, Ambarish

Sumarsono, Andrew; Sumarsono, Nathan; Das, Sandeep R; Vaduganathan, Muthiah; Agrawal, Deepak; Pandey, Ambarish.

Afiliação

Sumarsono A; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas.
Sumarsono N; Department of Pediatrics, Stanford University, Palo Alto, California.
Das SR; Division of Cardiology, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas.
Vaduganathan M; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Agrawal D; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas at Austin, Dell Medical School, Austin.
Pandey A; Division of Cardiology, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas.

JAMA Netw Open ; 3(2): e200181, 2020 02 05.

Article em En | MEDLINE | ID: mdl-32108893

Assuntos

Preparações de Ação Retardada/economia; Medicamentos Genéricos/economia; Medicaid/economia; Medicare Part D/economia; Estudos Transversais; Humanos; Equivalência Terapêutica; Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicaid / Medicamentos Genéricos / Preparações de Ação Retardada / Medicare Part D Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: JAMA Netw Open Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google